Scynexis (SCYX) Change in Receivables (2013 - 2023)
Scynexis' (SCYX) quarterly Change in Receivables came in at -$2.2 million in Q4 2023, down 472.7% on a YoY basis from $602354.6 in Q4 2022, and down 2167.68% quarter-over-quarter from -$99000.0 in Q3 2023.
Powered by 
Analysis
Scynexis (SCYX) Change in Receivables (2013 - 2023) Analysis & Trends
Scynexis (SCYX) has reported Change in Receivables for 5 consecutive years, with -$2.2 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Change in Receivables fell 472.7% year-over-year to -$2.2 million; the trailing twelve-month figure through Sep 2024 stood at -$2.2 million (down 805.24% YoY), and the FY2023 full-year result was -$2.1 million, down 269.44% from the prior year.
- Change in Receivables fell to -$2.2 million in Q4 2023 per SCYX's latest filing, from -$99000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $284000.0 in Q2 2023 and bottomed at -$2.2 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -2.25 Mn |
| Sep 30, 2023 | -99,000.00 |
| Jun 30, 2023 | 284,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Dec 31, 2022 | -392,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Dec 31, 2015 | -554,000.00 |
| Sep 30, 2015 | 309,000.00 |
| Jun 30, 2015 | 662,000.00 |
| Mar 31, 2015 | -448,000.00 |
| Dec 31, 2014 | 187,000.00 |
| Sep 30, 2014 | -142,000.00 |
| Jun 30, 2014 | 119,000.00 |
| Mar 31, 2014 | 275,000.00 |
| Dec 31, 2013 | -1.03 Mn |
| Sep 30, 2013 | -156,000.00 |
| Jun 30, 2013 | -414,000.00 |
| Mar 31, 2013 | 233,000.00 |